People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

Mounjaro, a tirzepatide drug prescribed for diabetes, could help people without this condition lose 13% of their body weight ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a microsimulation model. A multifaceted approach is needed to reduce financial barriers to obesity ...

More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound® As previously ...

As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...

The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity medications compared to lifestyle modification alone. Results indicate that ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...